Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
68 participants
INTERVENTIONAL
2009-03-31
2009-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Community-Based Cognitive Therapy for Suicide Attempters
NCT00081367
Mindfulness Based Cognitive Therapy for Depression and Cognitive Inhibition in Suicide
NCT02954250
A Randomized Clinical Trial Testing the Effectiveness of Telemental Health for Suicidal Patients
NCT04844294
An Autobiographical Memory-Based Intervention for Suicidality
NCT06225531
Development of a Treatment Prognosis Calculator for the Prevention of Suicide
NCT06094218
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 Cognitive Behavioural Therapy
Intervention group will receive a series of sessions of cognitive behaviour therapy. Delivery of CBT will be by three therapists; PI and two other Medical Officers. Each session will last for 30- 45 minutes and they will be delivered at the participant's residence (or at an alternative place of participant's choice) at two weeks intervals. They will be followed-up for three months from the cessation of CBT sessions.
Cognitive behavioural therapy
Will receive a series of sessions of cognitive behaviour therapy. Delivery of CBT will be by three therapists; PI and two other Medical Officers. Each session will last for 30- 45 minutes and they will be delivered at the participant's residence (or at an alternative place of participant's choice) at two weeks intervals. They will be followed-up for three months from the cessation of CBT sessions.
2 Treatment as usual
Will be referred to the MO(MH). They also will be followed-up for an equal length of time period as of the participants in the intervention group.
Treatment as usual
Will be referred to the MO(MH). They also will be followed-up for an equal length of time period as of the participants in the intervention group.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive behavioural therapy
Will receive a series of sessions of cognitive behaviour therapy. Delivery of CBT will be by three therapists; PI and two other Medical Officers. Each session will last for 30- 45 minutes and they will be delivered at the participant's residence (or at an alternative place of participant's choice) at two weeks intervals. They will be followed-up for three months from the cessation of CBT sessions.
Treatment as usual
Will be referred to the MO(MH). They also will be followed-up for an equal length of time period as of the participants in the intervention group.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self reported current active suicidal ideations
* Ability to speak and write Sinhala
Exclusion Criteria
* In-patient/out-patient treatment following an attempted suicide during the previous two-year period
* A diagnosis of mental retardation
* A diagnosis of sensory deficit
* A diagnosis of alcohol abuse
* A diagnosis of psychotic illness
18 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute of Psychiatry, London
OTHER
Institute for Research & Development Sri Lanka
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Institute for Research & Development
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sudath Samaraweera, MBBS MSc MD
Role: PRINCIPAL_INVESTIGATOR
Institute for Research & Development Sri Lanka
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute for Research & Development
Battaramulla, , Sri Lanka
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRD/03-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.